Effects of Micronized Trans-resveratrol Treatment on Clinical, Endocrine, Metabolic and Biochemical Parameters of Women With Polycystic Ovary Syndrome: Placebo-controlled Randomized Single-blind Study
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Resveratrol (Primary)
- Indications Embolism and thrombosis; Polycystic ovary syndrome
- Focus Therapeutic Use
- 07 Dec 2012 New trial record
- 02 Nov 2012 Biomarkers information updated